PureTech Health plc (LON:PRTC - Get Free Report)'s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 127.54 ($1.72) and traded as high as GBX 139.20 ($1.87). PureTech Health shares last traded at GBX 135 ($1.82), with a volume of 546,953 shares changing hands.
PureTech Health Stock Performance
The company has a market cap of £409.12 million, a P/E ratio of -5.59 and a beta of 1.02. The company's fifty day moving average is GBX 128.02 and its 200 day moving average is GBX 141.98. The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 45.82.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Recommended Stories
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
